The Utilization of Medication for Opioid Use Disorder in an Outpatient Setting-Presentation and Q&A

Video Transcription

Video Summary

Dr. Rob Cotez, Director of the Clinical and Research Program for Psychosis at Grady Health System and an Associate Professor at Emory University School of Medicine, welcomes viewers to the SMI Advisor webinar on deutilization of medication for opioid use disorder in an outpatient setting. The webinar is part of the APA and SAMHSA initiative called SMI Advisor, which aims to help clinicians implement evidence-based care for those with serious mental illness. The webinar offers one AMA PRA Category 1 credit for physicians and one Nursing Continuing Professional Development Contact Hour. Slides from the presentation are available for download. Viewers can submit questions throughout for the Q&A session at the end. Dr. Joseph Mathias, an addiction psychiatrist and Associate Director of Outpatient Addiction Services at Emory Healthcare, leads the webinar. He discusses comorbid psychiatric disorders with opioid use disorder, diagnosing OUD using the DSM-5 criteria, different medications for OUD, the importance of naloxone in preventing overdose deaths, ASAM's levels of care for OUD, and addressing stigma in addiction treatment. He emphasizes the importance of offering maintenance medication for all patients with OUD and highlights the unique considerations when working with adolescents and young adults with OUD. The webinar concludes with a Q&A session.

Keywords

Dr. Rob Cotez

Clinical and Research Program for Psychosis

Grady Health System

Associate Professor

Emory University School of Medicine

SMI Advisor

opioid use disorder

outpatient setting

APA

SAMHSA